|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - CTI BIOPHARMA CORP (CTIC)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-02-08 Purchase |
2018-02-12 9:59 pm |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
6,333,333 | $3 | $18,999,999 | 3,041,120 (Direct Indirect) |
View |
| 2017-09-28 Sale |
2017-10-02 5:25 pm |
CTI BIOPHARMA CORP | CTIC | LOVE RICHARD L Director |
14,600 | $3.208 | $46,837 | 84,318 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-09-18 Option Award |
2018-09-20 5:25 pm |
N/A 2028-09-18 |
CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. COO |
125,000 | $1.88 | 125,000 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 5:03 pm |
N/A 2028-09-18 |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID CFO |
125,000 | $1.88 | 125,000 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 4:46 pm |
N/A 2028-09-18 |
CTI BIOPHARMA CORP | CTIC | Craig Adam R CEO |
600,000 | $1.88 | 600,000 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 4:23 pm |
N/A 2028-09-18 |
CTI BIOPHARMA CORP | CTIC | Telling Fred Director |
60,000 | $1.88 | 60,000 (Direct) |
View |
| 2018-06-30 Option Award |
2018-07-02 4:49 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. COO |
500 | $2.295 | 31,500 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 7:01 pm |
N/A 2028-05-17 |
CTI BIOPHARMA CORP | CTI | PERRY MATTHEW D Director |
60,000 | $4.61 | 60,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-17 7:17 pm |
N/A 2028-05-17 |
CTI BIOPHARMA CORP | CTIC | Fischer Laurent Director |
60,000 | $4.61 | 60,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-17 6:55 pm |
N/A 2028-05-17 |
CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director |
60,000 | $4.61 | 60,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-17 6:37 pm |
N/A 2028-05-17 |
CTI BIOPHARMA CORP | CTIC | Parkinson David Ross Director |
60,000 | $4.61 | 60,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-17 6:20 pm |
N/A 2028-05-17 |
CTI BIOPHARMA CORP | CTIC | Telling Fred Director |
60,000 | $4.61 | 60,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-17 6:03 pm |
N/A 2028-05-17 |
CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director |
60,000 | $4.61 | 60,000 (Direct) |
View |
| 2018-05-16 Option Award |
2018-05-17 5:07 pm |
N/A 2028-05-16 |
CTI BIOPHARMA CORP | CTIC | Craig Adam R CEO |
475,000 | $4.14 | 475,000 (Direct) |
View |
| 2018-05-16 Option Award |
2018-05-17 4:49 pm |
N/A 2028-05-16 |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID CFO |
83,396 | $4.14 | 83,396 (Direct) |
View |
| 2018-05-16 Option Award |
2018-05-17 4:35 pm |
N/A 2028-05-16 |
CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. COO |
134,906 | $4.14 | 134,906 (Direct) |
View |
| 2018-05-16 Option Award |
2018-05-17 4:25 pm |
N/A 2028-05-16 |
CTI BIOPHARMA CORP | CTIC | SINGER JACK W EVP, Chief Scientific Officer |
94,433 | $4.14 | 94,433 (Direct) |
View |
| 2018-02-08 Disposition |
2018-02-12 9:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
3,566,549 | $0 | 3,041,120 (Direct) |
View |
| 2018-02-08 Disposition |
2018-02-12 9:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
2,295,083 | $0 | 3,041,120 (Direct) |
View |
| 2018-02-08 Disposition |
2018-02-12 9:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
651,074 | $0 | 3,041,120 (Direct) |
View |
| 2018-02-08 Disposition |
2018-02-12 9:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
1,487,294 | $0 | 3,041,120 (Indirect) |
View |
| 2018-02-08 Disposition |
2018-02-12 9:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
281 | $0 | 3,041,120 (Direct) |
View |
| 2018-02-08 Disposition |
2018-02-12 9:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
197 | $0 | 3,041,120 (Direct) |
View |
| 2018-02-08 Disposition |
2018-02-12 9:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
48 | $0 | 3,041,120 (Direct) |
View |
| 2018-02-08 Disposition |
2018-02-12 9:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
49 | $0 | 3,041,120 (Indirect) |
View |
| 2018-02-08 Option Award |
2018-02-12 9:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
5,631 | $0 | 3,041,120 (Direct) |
View |
| 2018-02-08 Option Award |
2018-02-12 9:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
3,640 | $0 | 3,041,120 (Direct) |
View |
| 2018-02-08 Option Award |
2018-02-12 9:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
1,024 | $0 | 3,041,120 (Direct) |
View |
| 2018-02-08 Option Award |
2018-02-12 9:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
2,280 | $0 | 3,041,120 (Indirect) |
View |
| 2018-01-20 Exercise |
2018-01-22 6:28 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director |
20,121 | $0 | 20,121 (Direct) |
View |
| 2018-01-20 Exercise |
2018-01-22 6:28 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director |
20,121 | $0 | 20,121 (Direct) |
View |
| 2017-08-31 Option Award |
2017-10-19 4:11 pm |
N/A 2027-08-31 |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID CFO |
25,000 | $3.25 | 25,000 (Direct) |
View |
| 2017-09-29 Option Award |
2017-10-03 5:16 pm |
N/A 2027-09-29 |
CTI BIOPHARMA CORP | CTIC | Craig Adam R CEO |
450,000 | $3.19 | 450,000 (Direct) |
View |
| 2017-09-29 Option Award |
2017-10-03 4:42 pm |
N/A 2027-09-29 |
CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. COO |
350,000 | $3.19 | 350,000 (Direct) |
View |
| 2017-09-29 Option Award |
2017-10-03 4:12 pm |
N/A 2027-09-29 |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID CFO |
315,000 | $3.19 | 315,000 (Direct) |
View |
| 2017-09-29 Option Award |
2017-10-03 3:16 pm |
N/A 2027-09-29 |
CTI BIOPHARMA CORP | CTIC | SINGER JACK W EVP, Chief Scientific Officer |
115,000 | $3.19 | 115,000 (Direct) |
View |
| 2017-09-20 Option Award |
2017-09-22 4:17 pm |
N/A 2027-09-19 |
CTI BIOPHARMA CORP | CTIC | LOVE RICHARD L Director |
50,000 | $4.25 | 50,000 (Direct) |
View |
| 2017-08-01 Option Award |
2017-08-03 7:02 pm |
N/A 2027-08-01 |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID See Remarks |
25,000 | $3.43 | 25,000 (Direct) |
View |
| 2017-07-21 Option Award |
2017-07-25 5:12 pm |
N/A 2027-07-21 |
CTI BIOPHARMA CORP | CTIC | Fischer Laurent Director |
50,000 | $3.41 | 50,000 (Direct) |
View |
| 2017-06-13 Conversion |
2017-06-15 5:40 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ISALY SAMUEL D 10% Owner |
5,000,000 | $0 | 5,000,000 (Indirect) |
View |
| 2017-06-13 Conversion |
2017-06-15 5:40 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ISALY SAMUEL D 10% Owner |
7,500 | $0 | 5,000,000 (Indirect) |
View |
| 2017-06-09 Conversion |
2017-06-14 4:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
2,007,333 | $0 | 3,566,549 (Direct) |
View |
| 2017-06-09 Conversion |
2017-06-14 4:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
1,410,000 | $0 | 3,566,549 (Direct) |
View |
| 2017-06-09 Conversion |
2017-06-14 4:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
342,000 | $0 | 3,566,549 (Direct) |
View |
| 2017-06-09 Conversion |
2017-06-14 4:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
357,333 | $0 | 3,566,549 (Indirect) |
View |
| 2017-06-09 Purchase |
2017-06-14 4:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
3,292 | $0 | 3,566,549 (Direct) |
View |
| 2017-06-09 Purchase |
2017-06-14 4:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
2,312 | $0 | 3,566,549 (Direct) |
View |
| 2017-06-09 Purchase |
2017-06-14 4:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
561 | $0 | 3,566,549 (Direct) |
View |
| 2017-06-09 Purchase |
2017-06-14 4:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
585 | $0 | 3,566,549 (Indirect) |
View |
| 2017-06-09 Conversion |
2017-06-14 4:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
3,011 | $0 | 3,566,549 (Direct) |
View |
| 2017-06-09 Conversion |
2017-06-14 4:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
2,115 | $0 | 3,566,549 (Direct) |
View |
| 2017-06-09 Conversion |
2017-06-14 4:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
513 | $0 | 3,566,549 (Direct) |
View |
| 2017-06-09 Conversion |
2017-06-14 4:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
536 | $0 | 3,566,549 (Indirect) |
View |
| 2017-06-05 Option Award |
2017-06-07 6:19 pm |
N/A 2027-06-05 |
CTI BIOPHARMA CORP | CTIC | Parkinson David Ross Director |
50,000 | $4.07 | 50,000 (Direct) |
View |
| 2017-04-28 Exercise |
2017-05-02 6:12 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTI | PERRY MATTHEW D Director |
34,736 | $0 | 43,139 (Direct) |
View |
| 2017-04-28 Exercise |
2017-05-02 6:12 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTI | PERRY MATTHEW D Director |
34,736 | $0 | 43,139 (Direct) |
View |
| 2017-04-29 Exercise |
2017-05-02 5:48 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | LOVE RICHARD L Director |
34,736 | $0 | 88,318 (Direct) |
View |
| 2017-04-29 Exercise |
2017-05-02 5:48 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | LOVE RICHARD L Director |
34,736 | $0 | 88,318 (Direct) |
View |
| 2017-04-29 Exercise |
2017-05-02 5:46 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Telling Fred Director |
34,736 | $0 | 78,874 (Direct) |
View |
| 2017-04-29 Exercise |
2017-05-02 5:46 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Telling Fred Director |
34,736 | $0 | 78,874 (Direct) |
View |
| 2017-04-29 Exercise |
2017-05-02 5:46 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | NUDELMAN PHILLIP M PHD Director |
39,698 | $0 | 73,129 (Direct) |
View |
| 2017-04-29 Exercise |
2017-05-02 5:46 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | NUDELMAN PHILLIP M PHD Director |
39,698 | $0 | 73,129 (Direct) |
View |
| 2017-04-29 Exercise |
2017-05-02 5:45 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director |
34,736 | $0 | 92,424 (Direct) |
View |
| 2017-04-29 Exercise |
2017-05-02 5:45 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director |
34,736 | $0 | 92,424 (Direct) |
View |
| 2017-03-20 Option Award |
2017-03-21 7:09 pm |
N/A 2027-03-19 |
CTI BIOPHARMA CORP | CTIC | Craig Adam R Director |
1,200,000 | $4.24 | 1,200,000 (Direct) |
View |
| 2017-03-01 Option Award |
2017-03-06 5:01 pm |
N/A 2027-02-28 |
CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. EVP, Chief Commercial Officer |
60,000 | $4.33 | 60,000 (Direct) |
View |
| 2017-03-01 Option Award |
2017-03-06 4:59 pm |
N/A 2027-02-28 |
CTI BIOPHARMA CORP | CTIC | Plunkett Matthew EVP, Chief Business Officer |
60,000 | $4.33 | 60,000 (Direct) |
View |
| 2017-03-01 Option Award |
2017-03-06 4:57 pm |
N/A 2027-02-28 |
CTI BIOPHARMA CORP | CTIC | SINGER JACK W EVP, Chief Scientific Officer |
60,000 | $4.33 | 60,000 (Direct) |
View |
| 2017-02-23 Option Award |
2017-02-27 7:10 pm |
N/A 2027-02-22 |
CTI BIOPHARMA CORP | CTI | PERRY MATTHEW D Director |
50,000 | $4.25 | 50,000 (Direct) |
View |
| 2017-02-23 Option Award |
2017-02-27 5:34 pm |
N/A 2027-02-22 |
CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director |
50,000 | $4.25 | 50,000 (Direct) |
View |
|
© 2005-2018 SecForm4.Com All rights reserved. Archives: 2018 2017 2016 2015 2014 2013 ... Fri, 14 Dec 2018 20:21:27 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |